Hedman H - Search Results

1

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.

Johansson M, Oudin A, Tiemann K, Bernard A, Golebiewska A, Keunen O, Fack F, Stieber D, Wang B, Hedman H, Niclou SP. Johansson M, et al. Among authors: hedman h. Neuro Oncol. 2013 Sep;15(9):1200-11. doi: 10.1093/neuonc/not054. Epub 2013 May 30. Neuro Oncol. 2013. PMID: 23723255 Free PMC article.

2

Estramustine-binding protein in malignant glioma in rat.

Karlsson AE, Björk P, Bergenheim AT, Sandström J, Hedman H, Henriksson R. Karlsson AE, et al. Among authors: hedman h. J Neurooncol. 2000 Aug;49(1):19-26. doi: 10.1023/a:1006494222148. J Neurooncol. 2000. PMID: 11131983

3

The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.

Vallbo C, Bergenheim T, Hedman H, Henriksson R. Vallbo C, et al. Among authors: hedman h. J Neurooncol. 2002 Jan;56(2):143-8. doi: 10.1023/a:1014562503097. J Neurooncol. 2002. PMID: 11995815

4

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis.

Thomasson M, Hedman H, Guo D, Ljungberg B, Henriksson R. Thomasson M, et al. Among authors: hedman h. Br J Cancer. 2003 Oct 6;89(7):1285-9. doi: 10.1038/sj.bjc.6601208. Br J Cancer. 2003. PMID: 14520461 Free PMC article.

5

Induction of apoptosis in resistant glioma cells by synthetic caspase-activation.

Karlsson T, Henriksson R, Hedman H. Karlsson T, et al. Among authors: hedman h. J Neurooncol. 2004 Jan;66(1-2):71-9. doi: 10.1023/b:neon.0000013485.09953.25. J Neurooncol. 2004. PMID: 15015772

6

LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.

Thomasson M, Wang B, Hammarsten P, Dahlman A, Persson JL, Josefsson A, Stattin P, Granfors T, Egevad L, Henriksson R, Bergh A, Hedman H. Thomasson M, et al. Among authors: hedman h. Int J Cancer. 2011 Jun 15;128(12):2843-52. doi: 10.1002/ijc.25820. Epub 2011 Apr 8. Int J Cancer. 2011. PMID: 21128282

7

Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.

Ghasimi S, Haapasalo H, Eray M, Korhonen K, Brännström T, Hedman H, Andersson U. Ghasimi S, et al. Among authors: hedman h. J Neurooncol. 2012 Jul;108(3):435-41. doi: 10.1007/s11060-012-0856-x. Epub 2012 Apr 8. J Neurooncol. 2012. PMID: 22484910 Free article.

8

Lrig2-deficient mice are protected against PDGFB-induced glioma.

Rondahl V, Holmlund C, Karlsson T, Wang B, Faraz M, Henriksson R, Hedman H. Rondahl V, et al. Among authors: hedman h. PLoS One. 2013 Sep 4;8(9):e73635. doi: 10.1371/journal.pone.0073635. eCollection 2013. PLoS One. 2013. PMID: 24023893 Free PMC article.

9

LRIG1 is a prognostic biomarker in non-small cell lung cancer.

Kvarnbrink S, Karlsson T, Edlund K, Botling J, Lindquist D, Jirström K, Micke P, Henriksson R, Johansson M, Hedman H. Kvarnbrink S, et al. Among authors: hedman h. Acta Oncol. 2015;54(8):1113-9. doi: 10.3109/0284186X.2015.1021427. Epub 2015 Mar 27. Acta Oncol. 2015. PMID: 25813475

10

Harnessing LRIG1-mediated inhibition of receptor tyrosine kinases for cancer therapy.

Neirinckx V, Hedman H, Niclou SP. Neirinckx V, et al. Among authors: hedman h. Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):109-116. doi: 10.1016/j.bbcan.2017.02.007. Epub 2017 Mar 1. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28259645 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters